GeoVax is currently conducting multiple site Phase 2 Human clinical trials for HIV /AIDS preventative vaccine products following successful completion of multiple ...
Editors' Note: This article covers a micro-cap stock. Please be aware of the risks associated with these stocks.) The Unique Preventive and Therapeutic HIV Vac.
Aids Vaccine Research - GeoVax, Inc. ... GeoVax HIV AIDS Vaccines ... cancer types in combination with other approaches to achieve a high cure rate.
Recent entry into high-profile Zika vaccine space with multiple collaborators ... vaccine candidate for prevention of HIV infection in the developed world (HIV ...
The Immune Space: A Concept and Template for Rationalizing Vaccine ... by a repeated dose SIVsmE660 challenge despite different immune responses.
Mar 27, 2017 ... HIV (Preventive Vaccine) – Our most advanced program is a ... and is a safety concern for other Zika vaccines under development, all of which ...
Several AIDS-causing HIV-1 virus subtypes, or "clades", exist in different regions throughout the world. These subtypes are identified as subtype A, subtype B on ...
The Need for an HIV/AIDS Vaccine. HIV/AIDS Facts. HIV/AIDS is the 5th leading cause of death globally; 34M people currently living with HIV (all clades) ...
There has been remarkable progress made against HIV / AIDS, in which the disease ... HIV is very different from most other vaccine-preventable viral diseases. .... GeoVax is also researching this technology in the immune-oncology space for ...
4 days ago ... GeoVax's HIV vaccine technology was developed in collaboration with ... owned by the NIH used to develop the Company's other vaccines.